Last 12 months
Inside the activity.
0 purchase rows · 0 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| July 11, 2022 Filed Aug 4, 2022 16:16 UTC |
Poirier Michael S.Director · Chairman and CEO
|
GrantStock Option (Right to Buy) · Derivative | 375,000 | $0.00 Strike: $0.51 | $0.00 |
DisclosureSEC source: 0001493152-22-021321 · ownership.xml · derivative · entry 1 Poirier Michael S. · CIK 0001812504 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 375,000 Underlying: Common Stock · 375,000 shares Expires 2032-07-11 F1 · derivative.exercise_date: Shares underlying the stock option vest over three years in equal annual installments from the date of grant. Read SEC document |
| July 11, 2022 Filed Aug 4, 2022 16:16 UTC |
ARSHAD TARIQSVP/Chief Medical Officer
|
GrantStock Option (Right to Buy) · Derivative | 102,000 | $0.00 Strike: $0.51 | $0.00 |
DisclosureSEC source: 0001493152-22-021326 · ownership.xml · derivative · entry 1 ARSHAD TARIQ · CIK 0001861399 · SVP/Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 102,000 Underlying: Common Stock · 102,000 shares Expires 2032-07-11 F1 · derivative.exercise_date: Shares underlying the stock option vest over three years in equal annual installments from the date of grant. Read SEC document |
| July 11, 2022 Filed Aug 4, 2022 16:17 UTC |
Abdul-Ahad WajdiVice President, R & D, CSO
|
GrantStock Option (Right to Buy) · Derivative | 80,000 | $0.00 Strike: $0.51 | $0.00 |
DisclosureSEC source: 0001493152-22-021324 · ownership.xml · derivative · entry 1 Abdul-Ahad Wajdi · CIK 0001812749 · Vice President, R & D, CSO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 80,000 Underlying: Common Stock · 80,000 shares Expires 2032-07-11 F1 · derivative.exercise_date: Shares underlying the stock option vest over three years in equal annual installments from the date of grant. Read SEC document |
| July 11, 2022 Filed Aug 4, 2022 16:16 UTC |
Sinha Shishir K.VP, COO & Secretary
|
GrantStock Option (Right to Buy) · Derivative | 100,000 | $0.00 Strike: $0.51 | $0.00 |
DisclosureSEC source: 0001493152-22-021318 · ownership.xml · derivative · entry 1 Sinha Shishir K. · CIK 0001812640 · VP, COO & Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 100,000 Underlying: Common Stock · 100,000 shares Expires 2032-07-11 F1 · derivative.exercise_date: Shares underlying the stock option vest over three years in equal annual installments from the date of grant. Read SEC document |
| July 11, 2022 Filed Aug 4, 2022 16:16 UTC |
David Richard A.Director
|
GrantStock Option (Right to Buy) · Derivative | 40,000 | $0.00 Strike: $0.51 | $0.00 |
DisclosureSEC source: 0001493152-22-021322 · ownership.xml · derivative · entry 1 David Richard A. · CIK 0001812663 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,000 Underlying: Common Stock · 40,000 shares Expires 2032-07-11 F1 · derivative.exercise_date: Shares underlying the stock option vest over three years in equal annual installments from the date of grant. Read SEC document |
| July 11, 2022 Filed Aug 4, 2022 16:16 UTC |
Lotz Christopher L.Vice President of Finance, CFO
|
GrantStock Option (Right to Buy) · Derivative | 100,000 | $0.00 Strike: $0.51 | $0.00 |
DisclosureSEC source: 0001493152-22-021323 · ownership.xml · derivative · entry 1 Lotz Christopher L. · CIK 0001812553 · Vice President of Finance, CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 100,000 Underlying: Common Stock · 100,000 shares Expires 2032-07-11 F1 · derivative.exercise_date: Shares underlying the stock option vest over three years in equal annual installments from the date of grant. Read SEC document |
| July 11, 2022 Filed Aug 4, 2022 20:16 UTC |
Kruger Kurt HDirector
|
GrantStock Option (Right to Buy) · Derivative | 40,000 | $0.00 Strike: $0.51 | $0.00 |
DisclosureSEC source: 0001493152-22-021325 · ownership.xml · derivative · entry 1 Kruger Kurt H · CIK 0001375881 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,000 Underlying: Common Stock · 40,000 shares Expires 2032-07-11 F1 · derivative.exercise_date: Shares underlying the stock option vest over three years in equal annual installments from the date of grant. Read SEC document |
| July 11, 2022 Filed Aug 4, 2022 20:16 UTC |
Ritter Ira E.Director
|
GrantStock Option (Right to Buy) · Derivative | 40,000 | $0.00 Strike: $0.51 | $0.00 |
DisclosureSEC source: 0001493152-22-021328 · ownership.xml · derivative · entry 1 Ritter Ira E. · CIK 0001631674 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,000 Underlying: Common Stock · 40,000 shares Expires 2032-07-11 F1 · derivative.exercise_date: Shares underlying the stock option vest over three years in equal annual installments from the date of grant. Read SEC document |
| July 11, 2022 Filed Aug 4, 2022 20:16 UTC |
Korenberg Matthew EDirector
|
GrantStock Option (Right to Buy) · Derivative | 40,000 | $0.00 Strike: $0.51 | $0.00 |
DisclosureSEC source: 0001493152-22-021319 · ownership.xml · derivative · entry 1 Korenberg Matthew E · CIK 0001649903 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,000 Underlying: Common Stock · 40,000 shares Expires 2032-07-11 F1 · derivative.exercise_date: Shares underlying the stock option vest over three years in equal annual installments from the date of grant. Read SEC document |
| July 11, 2022 Filed Aug 4, 2022 20:16 UTC |
EMERY SIDNEY W JRDirector
|
GrantStock Option (Right to Buy) · Derivative | 40,000 | $0.00 Strike: $0.51 | $0.00 |
DisclosureSEC source: 0001493152-22-021327 · ownership.xml · derivative · entry 1 EMERY SIDNEY W JR · CIK 0001183148 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,000 Underlying: Common Stock · 40,000 shares Expires 2032-07-11 F1 · derivative.exercise_date: Shares underlying the stock option vest over three years in equal annual installments from the date of grant. Read SEC document |
| July 11, 2022 Filed Aug 4, 2022 20:16 UTC |
BROIDRICK AMY S.Director · President/CSO
|
GrantStock Option (Right to Buy) · Derivative | 130,000 | $0.00 Strike: $0.51 | $0.00 |
DisclosureSEC source: 0001493152-22-021320 · ownership.xml · derivative · entry 1 BROIDRICK AMY S. · CIK 0001822917 · Director · President/CSO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 130,000 Underlying: Common Stock · 130,000 shares Expires 2032-07-11 F1 · derivative.exercise_date: Shares underlying the stock option vest over three years in equal annual installments from the date of grant. Read SEC document |
| June 22, 2022 Filed Jun 22, 2022 16:55 UTC |
Poirier Michael S.Director · Chairman and CEO
|
PurchaseCommon Stock | 30,000 | $0.57 | $17,100.00 |
DisclosureSEC source: 0001493152-22-017505 · ownership.xml · nonDerivative · entry 1 Poirier Michael S. · CIK 0001812504 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 199,202 Read SEC document |
| June 14, 2022 Filed Jun 15, 2022 20:05 UTC |
BROIDRICK AMY S.Director · President/CSO
|
PurchaseCommon Stock | 30,000 | $0.62 | $18,600.00 |
DisclosureSEC source: 0001493152-22-016857 · ownership.xml · nonDerivative · entry 1 BROIDRICK AMY S. · CIK 0001822917 · Director · President/CSO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,500 Read SEC document |
| December 08, 2021 Filed Dec 10, 2021 06:15 UTC |
ARSHAD TARIQSVP/Chief Medical Officer
|
GrantStock Option (Right to Buy) · Derivative | 300,000 | $0.00 Strike: $1.24 | $0.00 |
DisclosureSEC source: 0001493152-21-031058 · ownership.xml · derivative · entry 1 ARSHAD TARIQ · CIK 0001861399 · SVP/Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 300,000 Underlying: Common Stock · 300,000 shares Expires 2031-05-17 F1 · derivative.exercise_date: Shares underlying the stock option vest over two-plus years in three equal annual installments from the vesting commencement date of May 17, 2021. Read SEC document |
| December 08, 2021 Filed Dec 10, 2021 11:15 UTC |
BROIDRICK AMY S.Director · President/ChiefStrategyOfficer
|
GrantStock Option (Right to Buy) · Derivative | 300,000 | $0.00 Strike: $1.24 | $0.00 |
DisclosureSEC source: 0001493152-21-031059 · ownership.xml · derivative · entry 2 BROIDRICK AMY S. · CIK 0001822917 · Director · President/ChiefStrategyOfficer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 300,000 Underlying: Common Stock · 300,000 shares Expires 2031-12-08 F1 · derivative.exercise_date: Shares underlying the stock option vest over three years in three equal annual installments from the date of grant. Read SEC document |
| August 19, 2021 Filed Aug 20, 2021 19:05 UTC |
Kruger Kurt HDirector
|
PurchaseCommon Stock | 4,000 | $1.22 | $4,880.00 |
DisclosureSEC source: 0001493152-21-020787 · ownership.xml · nonDerivative · entry 2 Kruger Kurt H · CIK 0001375881 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,000 Read SEC document |
| August 19, 2021 Filed Aug 20, 2021 19:05 UTC |
Kruger Kurt HDirector
|
PurchaseCommon Stock | 4,000 | $1.23 | $4,920.00 |
DisclosureSEC source: 0001493152-21-020787 · ownership.xml · nonDerivative · entry 1 Kruger Kurt H · CIK 0001375881 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,000 Read SEC document |
| May 17, 2021 Filed May 18, 2021 06:14 UTC |
ARSHAD TARIQSVP/Chief Medical Officer
|
GrantStock Option (Right to Buy) · Derivative | 100,000 | $0.00 Strike: $1.80 | $0.00 |
DisclosureSEC source: 0001493152-21-012046 · ownership.xml · derivative · entry 1 ARSHAD TARIQ · CIK 0001861399 · SVP/Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 100,000 Underlying: Common Stock · 100,000 shares Expires 2031-05-17 F1 · derivative.exercise_date: Shares underlying the stock option vest over three years in three equal annual installments from the date of grant. Read SEC document |
| April 26, 2021 Filed Apr 26, 2021 22:16 UTC |
BROIDRICK AMY S.Director · EVP, Chief Strategy Officer
|
PurchaseCommon Stock | 4,500 | $2.03 | $9,135.00 |
DisclosureSEC source: 0001493152-21-009781 · ownership.xml · nonDerivative · entry 1 BROIDRICK AMY S. · CIK 0001822917 · Director · EVP, Chief Strategy Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,500 Read SEC document |
| April 20, 2021 Filed Apr 21, 2021 15:18 UTC |
Poirier Michael S.Director · Chairman, CEO & President
|
PurchaseCommon Stock | 11,005 | $1.80 | $19,809.00 |
DisclosureSEC source: 0001493152-21-009359 · ownership.xml · nonDerivative · entry 1 Poirier Michael S. · CIK 0001812504 · Director · Chairman, CEO & President 10b5-1 filing: Not disclosed Ownership: Indirect · By IRA Disclosed balance after: 11,005 Read SEC document |
| April 16, 2021 Filed Apr 19, 2021 06:15 UTC |
Lotz Christopher L.Vice President of Finance, CFO
|
PurchaseCommon Stock | 2,700 | $1.86 | $5,022.00 |
DisclosureSEC source: 0001493152-21-009073 · ownership.xml · nonDerivative · entry 1 Lotz Christopher L. · CIK 0001812553 · Vice President of Finance, CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,541 Read SEC document |
| December 29, 2020 Filed Dec 30, 2020 11:05 UTC |
Kruger Kurt HDirector
|
PurchaseCommon Stock | 4,000 | $2.94 | $11,740.00 |
DisclosureSEC source: 0001493152-20-024516 · ownership.xml · nonDerivative · entry 1 Kruger Kurt H · CIK 0001375881 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,000 Read SEC document |
| December 07, 2020 Filed Dec 8, 2020 17:31 UTC |
EMERY SIDNEY W JRDirector
|
GrantStock Option (Right to Buy) · Derivative | 50,000 | $0.00 Strike: $3.52 | $0.00 |
DisclosureSEC source: 0001493152-20-023102 · ownership.xml · derivative · entry 1 EMERY SIDNEY W JR · CIK 0001183148 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,000 Underlying: Common Stock · 50,000 shares Expires 2030-12-07 F1 · derivative.exercise_date: Shares underlying the stock option vest over three years in equal annual installments from the date of grant. Read SEC document |
| December 07, 2020 Filed Dec 29, 2020 21:44 UTC |
BROIDRICK AMY S.Director · Executive VP, CSO
|
GrantStock Option (Right to Buy) · Derivative | 150,000 | $0.00 Strike: $3.52 | $0.00 |
DisclosureSEC source: 0001493152-20-024462 · ownership.xml · derivative · entry 1 BROIDRICK AMY S. · CIK 0001822917 · Director · Executive VP, CSO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 150,000 Underlying: Common Stock · 150,000 shares Expires 2030-12-07 F1 · derivative.exercise_date: Shares underlying the stock option vest over three years in equal annual installments from the date of grant. Read SEC document |
| November 23, 2020 Filed Nov 24, 2020 02:11 UTC |
Kruger Kurt HDirector
|
PurchaseCommon Stock | 4,600 | $3.46 | $15,925.20 |
DisclosureSEC source: 0001493152-20-022337 · ownership.xml · nonDerivative · entry 2 Kruger Kurt H · CIK 0001375881 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,000 Read SEC document |
| November 20, 2020 Filed Nov 24, 2020 02:11 UTC |
Kruger Kurt HDirector
|
PurchaseCommon Stock | 1,400 | $3.55 | $4,968.60 |
DisclosureSEC source: 0001493152-20-022337 · ownership.xml · nonDerivative · entry 1 Kruger Kurt H · CIK 0001375881 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,400 Read SEC document |
| August 27, 2020 Filed Aug 28, 2020 18:01 UTC |
BROIDRICK AMY S.Director
|
GrantStock Option (Right to Buy) · Derivative | 50,000 | $0.00 Strike: $4.70 | $0.00 |
DisclosureSEC source: 0001493152-20-016892 · ownership.xml · derivative · entry 1 BROIDRICK AMY S. · CIK 0001822917 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,000 Underlying: Common Stock · 50,000 shares Expires 2030-08-27 F1 · derivative.exercise_date: Shares underlying the stock option vest over three years in equal annual installments from the date of grant. Read SEC document |
| June 06, 2020 Filed Jun 8, 2020 21:26 UTC |
Poirier Michael S.Director · Chairman, President & CEO
|
GrantStock Option (Right to Buy) · Derivative | 1,000,000 | $0.00 Strike: $5.13 | $0.00 |
DisclosureSEC source: 0001493152-20-010825 · ownership.xml · derivative · entry 1 Poirier Michael S. · CIK 0001812504 · Director · Chairman, President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,000,000 Underlying: Common Stock · 1,000,000 shares Expires 2030-06-06 F1 · derivative.exercise_date: Shares underlying the stock option vest over three years in equal annual installments from the date of grant. Read SEC document |
| June 06, 2020 Filed Jun 8, 2020 21:24 UTC |
Abdul-Ahad WajdiVice President, R & D, CSO
|
GrantStock Option (Right to Buy) · Derivative | 500,000 | $0.00 Strike: $5.13 | $0.00 |
DisclosureSEC source: 0001493152-20-010822 · ownership.xml · derivative · entry 1 Abdul-Ahad Wajdi · CIK 0001812749 · Vice President, R & D, CSO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 500,000 Underlying: Common Stock · 500,000 shares Expires 2030-06-06 F1 · derivative.exercise_date: Shares underlying the stock option vest over three years in equal annual installments from the date of grant. Read SEC document |
| June 06, 2020 Filed Jun 8, 2020 21:23 UTC |
Sinha Shishir K.Vice President of Operations
|
GrantStock Option (Right to Buy) · Derivative | 500,000 | $0.00 Strike: $5.13 | $0.00 |
DisclosureSEC source: 0001493152-20-010819 · ownership.xml · derivative · entry 1 Sinha Shishir K. · CIK 0001812640 · Vice President of Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 500,000 Underlying: Common Stock · 500,000 shares Expires 2030-06-06 F1 · derivative.exercise_date: Shares underlying the stock option vest over three years in equal annual installments from the date of grant. Read SEC document |
| June 06, 2020 Filed Jun 8, 2020 21:26 UTC |
David Richard A.Director
|
GrantStock Option (Right to Buy) · Derivative | 50,000 | $0.00 Strike: $5.13 | $0.00 |
DisclosureSEC source: 0001493152-20-010826 · ownership.xml · derivative · entry 1 David Richard A. · CIK 0001812663 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,000 Underlying: Common Stock · 50,000 shares Expires 2030-06-06 F1 · derivative.exercise_date: Shares underlying the stock option vest over three years in equal annual installments from the date of grant. Read SEC document |
| June 06, 2020 Filed Jun 8, 2020 21:21 UTC |
Lotz Christopher L.Vice President of Finance, CFO
|
GrantStock Option (Right to Buy) · Derivative | 600,000 | $0.00 Strike: $5.13 | $0.00 |
DisclosureSEC source: 0001493152-20-010816 · ownership.xml · derivative · entry 1 Lotz Christopher L. · CIK 0001812553 · Vice President of Finance, CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 600,000 Underlying: Common Stock · 600,000 shares Expires 2030-06-06 F1 · derivative.exercise_date: Shares underlying the stock option vest over three years in equal annual installments from the date of grant. Read SEC document |
| June 06, 2020 Filed Jun 9, 2020 01:27 UTC |
Ritter Ira E.Director
|
GrantStock Option (Right to Buy) · Derivative | 50,000 | $0.00 Strike: $5.13 | $0.00 |
DisclosureSEC source: 0001493152-20-010827 · ownership.xml · derivative · entry 1 Ritter Ira E. · CIK 0001631674 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,000 Underlying: Common Stock · 50,000 shares Expires 2030-06-06 F1 · derivative.exercise_date: Shares underlying the stock option vest over three years in equal annual installments from the date of grant. Read SEC document |
| June 06, 2020 Filed Jun 9, 2020 01:23 UTC |
Kruger Kurt HDirector
|
GrantStock Option (Right to Buy) · Derivative | 50,000 | $0.00 Strike: $5.13 | $0.00 |
DisclosureSEC source: 0001493152-20-010820 · ownership.xml · derivative · entry 1 Kruger Kurt H · CIK 0001375881 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,000 Underlying: Common Stock · 50,000 shares Expires 2030-06-06 F1 · derivative.exercise_date: Shares underlying the stock option vest over three years in equal annual installments from the date of grant. Read SEC document |
| June 06, 2020 Filed Jun 9, 2020 01:22 UTC |
Korenberg Matthew EDirector
|
GrantStock Option (Right to Buy) · Derivative | 50,000 | $0.00 Strike: $5.13 | $0.00 |
DisclosureSEC source: 0001493152-20-010817 · ownership.xml · derivative · entry 1 Korenberg Matthew E · CIK 0001649903 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,000 Underlying: Common Stock · 50,000 shares Expires 2030-06-06 F1 · derivative.exercise_date: Shares underlying the stock option vest over three years in equal annual installments from the date of grant. Read SEC document |
| May 22, 2020 Filed May 27, 2020 18:07 UTC |
Abdul-Ahad WajdiVP, R&D, CSO
|
OtherWarrant (Right to Buy) · Derivative | 8,857 | Not disclosed Strike: $2.54 | Not disclosed |
DisclosureSEC source: 0001493152-20-009961 · ownership.xml · derivative · entry 2 Abdul-Ahad Wajdi · CIK 0001812749 · VP, R&D, CSO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,857 Underlying: Common Stock · 8,857 shares Expires 2025-03-02 F1 · security: On May 22, 2020, a reverse merger transaction between the Issuer and Qualigen, Inc. ("Qualigen") was consummated such that Qualigen became a wholly-owned subsidiary of the Issuer (the "Merger"). Pursuant to and effective as of the closing of the Merger (the "Closing"), the Reporting Person became an officer of the Issuer. F2 · security: Immediately prior to the Closing, the Reporting Person held Qualigen Series C convertible preferred stock warrants. Pursuant to the Merger, the Qualigen Series C convertible preferred stock warrants previously held by the Reporting Person were assumed by the Issuer and may be exercised solely for shares of common stock of the Issuer. F2 · price: Immediately prior to the Closing, the Reporting Person held Qualigen Series C convertible preferred stock warrants. Pursuant to the Merger, the Qualigen Series C convertible preferred stock warrants previously held by the Reporting Person were assumed by the Issuer and may be exercised solely for shares of common stock of the Issuer. Read SEC document |
| May 22, 2020 Filed May 27, 2020 18:07 UTC |
Abdul-Ahad WajdiVP, R&D, CSO
|
OtherWarrant (Right to Buy) · Derivative | 7,971 | Not disclosed Strike: $2.07 | Not disclosed |
DisclosureSEC source: 0001493152-20-009961 · ownership.xml · derivative · entry 1 Abdul-Ahad Wajdi · CIK 0001812749 · VP, R&D, CSO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,971 Underlying: Common Stock · 7,971 shares Expires 2024-01-31 F1 · security: On May 22, 2020, a reverse merger transaction between the Issuer and Qualigen, Inc. ("Qualigen") was consummated such that Qualigen became a wholly-owned subsidiary of the Issuer (the "Merger"). Pursuant to and effective as of the closing of the Merger (the "Closing"), the Reporting Person became an officer of the Issuer. F2 · security: Immediately prior to the Closing, the Reporting Person held Qualigen Series C convertible preferred stock warrants. Pursuant to the Merger, the Qualigen Series C convertible preferred stock warrants previously held by the Reporting Person were assumed by the Issuer and may be exercised solely for shares of common stock of the Issuer. F2 · price: Immediately prior to the Closing, the Reporting Person held Qualigen Series C convertible preferred stock warrants. Pursuant to the Merger, the Qualigen Series C convertible preferred stock warrants previously held by the Reporting Person were assumed by the Issuer and may be exercised solely for shares of common stock of the Issuer. Read SEC document |
| May 22, 2020 Filed May 27, 2020 18:05 UTC |
Sinha Shishir K.Vice President of Operations
|
OtherWarrant (Right to Buy) · Derivative | 26,570 | Not disclosed Strike: $2.07 | Not disclosed |
DisclosureSEC source: 0001493152-20-009960 · ownership.xml · derivative · entry 2 Sinha Shishir K. · CIK 0001812640 · Vice President of Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,570 Underlying: Common Stock · 26,570 shares Expires 2024-08-20 F1 · security: On May 22, 2020, a reverse merger transaction between the Issuer and Qualigen, Inc. ("Qualigen") was consummated such that Qualigen became a wholly-owned subsidiary of the Issuer (the "Merger"). Pursuant to and effective as of the closing of the Merger (the "Closing"), the Reporting Person became an officer of the Issuer. F2 · security: Immediately prior to the Closing, the Reporting Person held Qualigen Series C convertible preferred stock warrants. Pursuant to the Merger, the Qualigen Series C convertible preferred stock warrants previously held by the Reporting Person were assumed by the Issuer and may be exercised solely for shares of common stock of the Issuer. F2 · price: Immediately prior to the Closing, the Reporting Person held Qualigen Series C convertible preferred stock warrants. Pursuant to the Merger, the Qualigen Series C convertible preferred stock warrants previously held by the Reporting Person were assumed by the Issuer and may be exercised solely for shares of common stock of the Issuer. Read SEC document |
| May 22, 2020 Filed May 27, 2020 18:05 UTC |
Sinha Shishir K.Vice President of Operations
|
OtherWarrant (Right to Buy) · Derivative | 8,857 | Not disclosed Strike: $2.07 | Not disclosed |
DisclosureSEC source: 0001493152-20-009960 · ownership.xml · derivative · entry 1 Sinha Shishir K. · CIK 0001812640 · Vice President of Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,857 Underlying: Common Stock · 8,857 shares Expires 2024-01-31 F1 · security: On May 22, 2020, a reverse merger transaction between the Issuer and Qualigen, Inc. ("Qualigen") was consummated such that Qualigen became a wholly-owned subsidiary of the Issuer (the "Merger"). Pursuant to and effective as of the closing of the Merger (the "Closing"), the Reporting Person became an officer of the Issuer. F2 · security: Immediately prior to the Closing, the Reporting Person held Qualigen Series C convertible preferred stock warrants. Pursuant to the Merger, the Qualigen Series C convertible preferred stock warrants previously held by the Reporting Person were assumed by the Issuer and may be exercised solely for shares of common stock of the Issuer. F2 · price: Immediately prior to the Closing, the Reporting Person held Qualigen Series C convertible preferred stock warrants. Pursuant to the Merger, the Qualigen Series C convertible preferred stock warrants previously held by the Reporting Person were assumed by the Issuer and may be exercised solely for shares of common stock of the Issuer. Read SEC document |
| May 22, 2020 Filed May 27, 2020 18:04 UTC |
Poirier Michael S.Director · Chairman, President & CEO.
|
OtherWarrant (Right to Buy) · Derivative | 14,437 | Not disclosed Strike: $2.54 | Not disclosed |
DisclosureSEC source: 0001493152-20-009959 · ownership.xml · derivative · entry 5 Poirier Michael S. · CIK 0001812504 · Director · Chairman, President & CEO. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,437 Underlying: Common Stock · 14,437 shares Expires 2026-09-22 F3 · security: Pursuant to the Merger, Qualigen Series C convertible preferred stock warrants previously held by the Reporting Person were assumed by the Issuer and may be exercised solely for shares of common stock of the Issuer. F3 · price: Pursuant to the Merger, Qualigen Series C convertible preferred stock warrants previously held by the Reporting Person were assumed by the Issuer and may be exercised solely for shares of common stock of the Issuer. Read SEC document |
| May 22, 2020 Filed May 27, 2020 18:04 UTC |
Poirier Michael S.Director · Chairman, President & CEO.
|
OtherWarrant (Right to Buy) · Derivative | 22,142 | Not disclosed Strike: $2.54 | Not disclosed |
DisclosureSEC source: 0001493152-20-009959 · ownership.xml · derivative · entry 4 Poirier Michael S. · CIK 0001812504 · Director · Chairman, President & CEO. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,142 Underlying: Common Stock · 22,142 shares Expires 2025-03-02 F3 · security: Pursuant to the Merger, Qualigen Series C convertible preferred stock warrants previously held by the Reporting Person were assumed by the Issuer and may be exercised solely for shares of common stock of the Issuer. F3 · price: Pursuant to the Merger, Qualigen Series C convertible preferred stock warrants previously held by the Reporting Person were assumed by the Issuer and may be exercised solely for shares of common stock of the Issuer. Read SEC document |
| May 22, 2020 Filed May 27, 2020 18:04 UTC |
Poirier Michael S.Director · Chairman, President & CEO.
|
OtherWarrant (Right to Buy) · Derivative | 29,847 | Not disclosed Strike: $2.07 | Not disclosed |
DisclosureSEC source: 0001493152-20-009959 · ownership.xml · derivative · entry 3 Poirier Michael S. · CIK 0001812504 · Director · Chairman, President & CEO. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,847 Underlying: Common Stock · 29,847 shares Expires 2024-08-02 F3 · security: Pursuant to the Merger, Qualigen Series C convertible preferred stock warrants previously held by the Reporting Person were assumed by the Issuer and may be exercised solely for shares of common stock of the Issuer. F3 · price: Pursuant to the Merger, Qualigen Series C convertible preferred stock warrants previously held by the Reporting Person were assumed by the Issuer and may be exercised solely for shares of common stock of the Issuer. Read SEC document |
| May 22, 2020 Filed May 27, 2020 18:04 UTC |
Poirier Michael S.Director · Chairman, President & CEO.
|
OtherWarrant (Right to Buy) · Derivative | 22,142 | Not disclosed Strike: $2.07 | Not disclosed |
DisclosureSEC source: 0001493152-20-009959 · ownership.xml · derivative · entry 2 Poirier Michael S. · CIK 0001812504 · Director · Chairman, President & CEO. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,142 Underlying: Common Stock · 22,142 shares Expires 2024-01-31 F3 · security: Pursuant to the Merger, Qualigen Series C convertible preferred stock warrants previously held by the Reporting Person were assumed by the Issuer and may be exercised solely for shares of common stock of the Issuer. F3 · price: Pursuant to the Merger, Qualigen Series C convertible preferred stock warrants previously held by the Reporting Person were assumed by the Issuer and may be exercised solely for shares of common stock of the Issuer. Read SEC document |
| May 22, 2020 Filed May 27, 2020 18:04 UTC |
Poirier Michael S.Director · Chairman, President & CEO.
|
OtherCommon Stock | 169,192 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001493152-20-009959 · ownership.xml · nonDerivative · entry 1 Poirier Michael S. · CIK 0001812504 · Director · Chairman, President & CEO. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 169,192 F1 · security: On May 22, 2020, a reverse merger transaction between the Issuer and Qualigen, Inc. ("Qualigen") was consummated such that Qualigen became a wholly-owned subsidiary of the Issuer (the "Merger"). Pursuant to and effective as of the closing of the Merger (the "Closing"), the Reporting Person became an officer and director of the Issuer. F2 · security: Immediately prior to the Closing, the Reporting Person was a stockholder of Qualigen. Pursuant to the Merger, the shares of Qualigen common stock previously held by the Reporting Person were converted into 169,192 shares of common stock of the Issuer. F2 · kind: Immediately prior to the Closing, the Reporting Person was a stockholder of Qualigen. Pursuant to the Merger, the shares of Qualigen common stock previously held by the Reporting Person were converted into 169,192 shares of common stock of the Issuer. F2 · price: Immediately prior to the Closing, the Reporting Person was a stockholder of Qualigen. Pursuant to the Merger, the shares of Qualigen common stock previously held by the Reporting Person were converted into 169,192 shares of common stock of the Issuer. Read SEC document |
| May 22, 2020 Filed May 27, 2020 17:59 UTC |
David Richard A.Director
|
OtherWarrant (Right to Buy) · Derivative | 8,857 | Not disclosed Strike: $2.54 | Not disclosed |
DisclosureSEC source: 0001493152-20-009956 · ownership.xml · derivative · entry 1 David Richard A. · CIK 0001812663 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,857 Underlying: Common Stock · 8,857 shares Expires 2027-06-26 F1 · security: On May 22, 2020, a reverse merger transaction between the Issuer and Qualigen, Inc. ("Qualigen") was consummated such that Qualigen became a wholly-owned subsidiary of the Issuer (the "Merger"). Pursuant to and effective as of the closing of the Merger (the "Closing"), the Reporting Person became a director of the Issuer. F2 · security: Immediately prior to the Closing, the Reporting Person held Qualigen Series C convertible preferred stock warrants. Pursuant to the Merger, the Qualigen Series C convertible preferred stock warrants previously held by the Reporting Person were assumed by the Issuer and may be exercised solely for shares of common stock of the Issuer. F2 · price: Immediately prior to the Closing, the Reporting Person held Qualigen Series C convertible preferred stock warrants. Pursuant to the Merger, the Qualigen Series C convertible preferred stock warrants previously held by the Reporting Person were assumed by the Issuer and may be exercised solely for shares of common stock of the Issuer. Read SEC document |
| May 22, 2020 Filed May 27, 2020 18:03 UTC |
Lotz Christopher L.VP of Finance, CFO.
|
OtherWarrant (Right to Buy) · Derivative | 3,543 | Not disclosed Strike: $2.54 | Not disclosed |
DisclosureSEC source: 0001493152-20-009958 · ownership.xml · derivative · entry 5 Lotz Christopher L. · CIK 0001812553 · VP of Finance, CFO. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,543 Underlying: Common Stock · 3,543 shares Expires 2026-09-22 F3 · security: Pursuant to the Merger, Qualigen Series C convertible preferred stock warrants previously held by the Reporting Person were assumed by the Issuer and may be exercised solely for shares of common stock of the Issuer. F3 · price: Pursuant to the Merger, Qualigen Series C convertible preferred stock warrants previously held by the Reporting Person were assumed by the Issuer and may be exercised solely for shares of common stock of the Issuer. Read SEC document |
| May 22, 2020 Filed May 27, 2020 18:03 UTC |
Lotz Christopher L.VP of Finance, CFO.
|
OtherWarrant (Right to Buy) · Derivative | 22,142 | Not disclosed Strike: $2.54 | Not disclosed |
DisclosureSEC source: 0001493152-20-009958 · ownership.xml · derivative · entry 4 Lotz Christopher L. · CIK 0001812553 · VP of Finance, CFO. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,142 Underlying: Common Stock · 22,142 shares Expires 2025-03-02 F3 · security: Pursuant to the Merger, Qualigen Series C convertible preferred stock warrants previously held by the Reporting Person were assumed by the Issuer and may be exercised solely for shares of common stock of the Issuer. F3 · price: Pursuant to the Merger, Qualigen Series C convertible preferred stock warrants previously held by the Reporting Person were assumed by the Issuer and may be exercised solely for shares of common stock of the Issuer. Read SEC document |
| May 22, 2020 Filed May 27, 2020 18:03 UTC |
Lotz Christopher L.VP of Finance, CFO.
|
OtherWarrant (Right to Buy) · Derivative | 29,847 | Not disclosed Strike: $2.07 | Not disclosed |
DisclosureSEC source: 0001493152-20-009958 · ownership.xml · derivative · entry 3 Lotz Christopher L. · CIK 0001812553 · VP of Finance, CFO. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,847 Underlying: Common Stock · 29,847 shares Expires 2024-08-02 F3 · security: Pursuant to the Merger, Qualigen Series C convertible preferred stock warrants previously held by the Reporting Person were assumed by the Issuer and may be exercised solely for shares of common stock of the Issuer. F3 · price: Pursuant to the Merger, Qualigen Series C convertible preferred stock warrants previously held by the Reporting Person were assumed by the Issuer and may be exercised solely for shares of common stock of the Issuer. Read SEC document |
| May 22, 2020 Filed May 27, 2020 18:03 UTC |
Lotz Christopher L.VP of Finance, CFO.
|
OtherWarrant (Right to Buy) · Derivative | 22,142 | Not disclosed Strike: $2.07 | Not disclosed |
DisclosureSEC source: 0001493152-20-009958 · ownership.xml · derivative · entry 2 Lotz Christopher L. · CIK 0001812553 · VP of Finance, CFO. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,142 Underlying: Common Stock · 22,142 shares Expires 2024-01-31 F3 · security: Pursuant to the Merger, Qualigen Series C convertible preferred stock warrants previously held by the Reporting Person were assumed by the Issuer and may be exercised solely for shares of common stock of the Issuer. F3 · price: Pursuant to the Merger, Qualigen Series C convertible preferred stock warrants previously held by the Reporting Person were assumed by the Issuer and may be exercised solely for shares of common stock of the Issuer. Read SEC document |
| May 22, 2020 Filed May 27, 2020 18:03 UTC |
Lotz Christopher L.VP of Finance, CFO.
|
OtherCommon Stock | 9,841 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001493152-20-009958 · ownership.xml · nonDerivative · entry 1 Lotz Christopher L. · CIK 0001812553 · VP of Finance, CFO. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,841 F1 · security: On May 22, 2020, a reverse merger transaction between the Issuer and Qualigen, Inc. ("Qualigen") was consummated such that Qualigen became a wholly-owned subsidiary of the Issuer (the "Merger"). Pursuant to and effective as of the closing of the Merger (the "Closing"), the Reporting Person became an officer of the Issuer. F2 · security: Immediately prior to the Closing, the Reporting Person was a stockholder of Qualigen. Pursuant to the Merger, the shares of Qualigen common stock previously held by the Reporting Person were converted into 9,841 shares of common stock of the Issuer. F2 · kind: Immediately prior to the Closing, the Reporting Person was a stockholder of Qualigen. Pursuant to the Merger, the shares of Qualigen common stock previously held by the Reporting Person were converted into 9,841 shares of common stock of the Issuer. F2 · price: Immediately prior to the Closing, the Reporting Person was a stockholder of Qualigen. Pursuant to the Merger, the shares of Qualigen common stock previously held by the Reporting Person were converted into 9,841 shares of common stock of the Issuer. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.